Neuroprotection of taurine against bilirubin-induced elevation of apoptosis and intracellular free calcium ion in vivo

Toxicology Mechanisms and Methods

Volumn 21, Issue 5, 2011, Pages 383-387

  Gao, Xiaoling ^a   Yang, Xi ^b   Zhang, Benzhong ^c  

^a GANSU PROVINCIAL HOSPITAL   (China)

^b UNIVERSITY OF MANITOBA   (Canada)

^c LANZHOU UNIVERSITY   (China)

Author keywords

apoptosis; bilirubin; hyperbilirubinemia; intracellular free calcium ion; Taurine

Indexed keywords

BILIRUBIN; CALCIUM ION; CASPASE 3; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENETIC TRANSCRIPTION; HYPERBILIRUBINEMIA; IN VIVO STUDY; MALE; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NEWBORN JAUNDICE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BILIRUBIN; BRAIN; CALCIUM; CALCIUM SIGNALING; CASPASE 3; DISEASE MODELS, ANIMAL; FEMALE; HYPERBILIRUBINEMIA, NEONATAL; MALE; MICE; MICE, INBRED STRAINS; NEUROPROTECTIVE AGENTS; TAURINE;

MURINAE; MUS;

EID: 79957489940     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2010.546815     Document Type: Article

References (25)

1. Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, Mocchetti I. 2001. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21:3104-3112. (Pubitemid 32323492)
2. Bhutani VK, Johnson L. 2009. Kernicterus in the 21st century: frequently asked questions. J Perinatol 29(Suppl 1):20-24.
3. Birdsall TC. 1998. Therapeutic applications of taurine. Altern Med Rev 3:128-136. (Pubitemid 128709608)
4. Brosnan JT, Brosnan ME. 2006. The sulfur-containing amino acids: an overview. J Nutr 136:1636S-1640S. (Pubitemid 43765374)
5. Du Y, Dodel RC, Bales KR, Jemmerson R, Hamilton-Byrd E, Paul SM. 1997. Involvement of a caspase-3-like cysteine protease in 1-methyl-4- phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J Neurochem 69:1382-1388. (Pubitemid 27406938)
6. Grojean S, Koziel V, Vert P, Daval JL. 2000. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol 166:334-341.
7. Hagar HH. 2004. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 151:335-343. (Pubitemid 38759297)
8. Hankø E, Hansen TW, Almaas R, Rootwelt T. 2006. Recovery after shortterm bilirubin exposure in human NT2-N neurons. Brain Res 1103: 56-64. (Pubitemid 44080119)
9. Johnson LH, Bhutani VK, Brown AK. 2002. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 140:396-403. (Pubitemid 34494310)
10. Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L, Chan SL, Chrest FJ, Emokpae R Jr, Gorospe M, Mattson MP. 2004. Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41: 549-561. (Pubitemid 38253067)
11. Morales I, Dopico JG, Sabate M, Gonzalez-Hernandez T, Rodriguez M. 2007. Substantia nigra osmoregulation: taurine and ATP involvement. Am J Physiol, Cell Physiol 292:C1934-C1941. (Pubitemid 47080579)
12. Okuda T, Kadotsuji K, Takayama C, Hanada K, Mukaizawa F, Ogawara K, Higaki K, Kimura T. 2006. Involvement of intracellular Ca2+ dynamics in cytoprotective action by amino acids and cytotoxicity by sodium laurate, an absorption enhancer. J Pharm Sci 95:2256-2265. (Pubitemid 44568535)
13. Palackal T, Moretz R, Wisniewski H, Sturman J. 1986. Abnormal visual cortex development in the kitten associated with maternal dietary taurine deprivation. J Neurosci Res 15:223-239. (Pubitemid 16168216)
14. Paredes RM, Etzler JC, Watts LT, Zheng W, Lechleiter JD. 2008. Chemical calcium indicators. Methods 46:143-151.
15. Paula-Lima AC, De Felice FG, Brito-Moreira J, Ferreira ST. 2005. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 49:1140-1148. (Pubitemid 41608638)
16. Pion PD, Kittleson MD, Rogers QR, Morris JG. 1987. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764-768. (Pubitemid 17128269)
17. Rodrigues CM, Solá S, Silva R, Brites D. 2000. Bilirubin and amyloid-beta peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol Med 6:936-946.
18. Sakhi S, Sun N, Wing LL, Mehta P, Schreiber SS. 1996. Nuclear accumulation of p53 protein following kainic acid-induced seizures. Neuroreport 7:493-496. (Pubitemid 26105025)
19. Sturman JA. 1993. Taurine in development. Physiol Rev 73:119-147.
20. Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T, Schaffer SW, Azuma J. 2003. Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. J Cardiovasc Pharmacol 41:726-733. (Pubitemid 36523175)
21. Tenneti L, Lipton SA. 2000. Involvement of activated caspase-3-like proteases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem 74:134-142. (Pubitemid 30012763)
22. Uberti D, Belloni M, Grilli M, Spano P, Memo M. 1998. Induction of tumoursuppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur J Neurosci 10: 246-254. (Pubitemid 28325446)
23. Wu T, Ding XS, Wang W, Wu J. 2006. MCI-186 (3-methyl-1-phenyl-2- pyrazolin- 5-one) attenuated simulated ischemia/reperfusion injury in cultured rat hippocampal cells. Biol Pharm Bull 29:1613-1617. (Pubitemid 44166361)
24. Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS. 1996. Evidence for p53-mediated modulation of neuronal viability. J Neurosci 16:6753-6765. (Pubitemid 26359359)
25. Zhang B, Yang X, Gao X. 2010. Taurine protects against bilirubin-induced neurotoxicity in vitro. Brain Res 1320:159-167.